Health Canada’s Requirements for Devices: Approval, Compliance…and the Changes Now Being Implemented

Presented by Ms. Geihan (Gigi) Rizkalla; Tuesday, June 21, 2016; 1:00pm – 2:30pm EDT (GMT -4)

Sales of medical devices in Canada are estimated to make up the world’s 9th richest market for these commodities, and financial experts continue to release favorable forecasts. Many of these devices are imported…and manufacturers shipping products to Canada must be aware of their legal obligations.

Regulations for introducing and keeping devices on the Canadian market are not the same as the rules used at the FDA. Some differences are quite subtle, others are very substantial. Now, even manufacturers with long experience in the Canadian market are facing compliance challenges.

In 2014, the Canadian government enacted sweeping changes to the Food and Drugs Act, and manufacturers of medical devices must adapt to Health Canada’s strengthened enforcement programs and heightened public transparency requirements.

On June 21, 2016 FOI hosted a 90-minute, audio-format presentation describing the current Canadian regulatory process for approving medical devices – and, once approved, keeping them on the market in a climate that brought Health Canada broad new powers and a new organization to deliver compliance and enforcement programs. You'll come away with an understanding of the steps to market authorization, the classification system for devices and an overview of the compliance process...including the common misunderstandings and the potential consequences of non-compliance.

Topics Covered Include:

What You'll Get:

Who Should Attend:

About Your Instructor:

Geihan (Gigi) Rizkalla, B.Sc., M.Sc., ASQ has over 25 years of experience in Canadian and US medical devices regulatory affairs and compliance. Gigi began her career working with medical products over 20 years ago. She progressed quickly through quality assurance and control roles of increasing responsibility at medium and large medical devices companies, rising to Director of QA/QC at a major Canadian diagnostics company. In addition to her long experience developing and maintaining Quality Management Systems to ensure compliance with ISO 13485 CMDCAS and FDA 21 CFR Part 820, Gigi is highly skilled in successfully preparing and filing Class II, III and IV medical device license submissions with Health Canada. For the past four years she has been an Associate with McCarthy Consultant Services, Inc. (MCSI), spearheading many medical device projects.

If you have questions about the content and coverage of this presentation, you are invited to contact MCSI directly at smccarthy@mccarthyconsultant.com. For more information about MCSI, a respected Canadian regulatory consulting dedicated to helping drug and device firms worldwide, visit the company’s website at www.mccarthyconsultant.com.

Where:

In your office, conference room – or anywhere else you are!

Get the MP3 & Slides

Try the Audio Package for $449. The package includes online delivery of an mp3 file of the entire presentation, including the question and answer session, as well as all of the handouts.